Kidney Disease Clinical Trials in San Antonio

Showing 301-320 of 340 trials

Fasiglifam in Type 2 Diabetic Subjects With Chronic Kidney Disease Stage 4 or 5 on Hemodialysis

NCT02015780

To evaluate the efficacy of fasiglifam 50 mg once daily compared to placebo on glycemic control as measured by glycosilated haemoglobin (HbA1c) over a 16-week treatment period in participants with Type 2 Diabetes Mellitus (T2DM) and chronic kidney disease (CKD) stage 4 or 5 on dialysis.

Type 2 Diabetes MellitusChronic Kidney Disease

TakedaStarted Dec 2013

Whittier, California, United States • Westminster, Colorado, United States • Tampa, Florida, United States +27 more locations

COMPLETEDPhase 1< 1 mile

Safety Study of GCS-100 to Treat Chronic Kidney Disease

NCT01717248

The purpose of this study is to evaluate the safety of GCS-100 as a treatment for chronic kidney disease.

Chronic Kidney Disease

La Jolla Pharmaceutical Company29 participantsStarted Jan 2013

Tempe, Arizona, United States • La Mesa, California, United States • Denver, Colorado, United States +1 more locations

Fasiglifam in Type 2 Diabetic Subjects With Chronic Kidney Disease Stage 4 or 5 on Hemodialysis

Safety Study of GCS-100 to Treat Chronic Kidney Disease

Kidney Disease Trials in Other Cities

The PRIMO Study: Paricalcitol Capsules Benefits Renal Failure Induced Cardiac Morbidity in Subjects With Chronic Kidney Disease Stage 3/4

Erlotinib in Treating Patients With Locally Advanced or Metastatic Papillary Renal Cell Cancer

Sorafenib and Interferon Alfa in Treating Patients With Metastatic or Unresectable Kidney Cancer

Safety & Efficacy of Peginesatide for Maintenance Treatment of Anemia in Participants With Chronic Kidney Disease on Hemodialysis

Safety and Efficacy of Peginesatide for the Treatment of Anemia in Participants With Chronic Renal Failure Not on Dialysis

Safety & Efficacy of Peginesatide for the Treatment of Anemia in Participants With Chronic Renal Failure Not on Dialysis

S0031, ZD 1839 in Treating Patients With Advanced Cancer of the Urinary Tract

Study to Compare Sevelamer Carbonate Powder to Sevelamer Hydrochloride Tablets in Patients With CKD on Hemodialysis

Study to Evaluate the Prospective Payment System

A Prospective, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate Efficacy and Safety of Atrasentan, Including Thoracic Bioimpedance, in Type 2 Diabetic Subjects With Nephropathy

A Drug-Drug Interaction Study of the Effects of XL184 (Cabozantinib) on Rosiglitazone in Subjects With Solid Tumors

Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors

Study of ABT-869 in Subjects With Advanced Renal Cell Carcinoma Who Have Previously Received Treatment With Sunitinib

Combination Chemotherapy Plus Filgrastim in Treating Patients With Locally Recurrent or Advanced Urothelium Cancer

Kidney and Liver Transplantation in People With HIV

Randomized Study of Sorafenib Dose Escalation in Patients With Previously Untreated Metastatic Renal Cell Carcinoma

REFORM Clinical Study: Treatment of Renal Artery Stenosis With the Formula Balloon-Expandable Stent

Pharmacokinetics (PK) of Dalfampridine-ER 7.5 mg BID in Healthy Volunteers and Subjects With Mild or Moderate Renal Impairment

Other Conditions in San Antonio